Carvajal Alejandra
Officer at Mersana Therapeutics, Inc.; Chief Legal Officer at MOMENTA PHARMACEUTICALS INC
- Sold, on record
- $1.5M
- Dollars the filings state
- Form 4 sales
- 22
- Latest Jan 16, 2025
- Form 144 notices
- 2
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Mersana Therapeutics, Inc.Officer
- MOMENTA PHARMACEUTICALS INCChief Legal Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- MOMENTA PHARMACEUTICALS INC57,292 shares
- Mersana Therapeutics, Inc.36,120 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Mersana Therapeutics, Inc.RoutineApr 27, 2023 2023
Sold 3,944 shares at $3.89 ($15k)
Carvajal Alejandra, SVP, Chief Legal Officer
10b5-1 planSold 16.3% of holdings ($94k position)20,326 shares leftFiling
- 2 Form 4 sale Mersana Therapeutics, Inc.RoutineJan 16, 2024 +264 days
Sold 4,381 shares at $2.71 ($12k)
Carvajal Alejandra, SVP, Chief Legal Officer
10b5-1 planSold 13.8% of holdings ($86k position)27,403 shares left1.1x usual sizeFiling
- 3 Form 4 sale Mersana Therapeutics, Inc.UnusualOct 3, 2024 +261 days
Sold 13,687 shares at $1.98 ($27k)
Carvajal Alejandra, SVP, Chief Legal Officer
10b5-1 planSold 17.7% of holdings ($154k position)63,716 shares left3.5x usual sizeFiling
- 4 Form 144 notice Mersana Therapeutics, Inc.NoticeOct 7, 2024 +4 days
Filed to sell 13,687 shares ($28k)
Carvajal Alejandra, Officer
10b5-1 plan3.3x usual sizeFiling
- 5 Form 4 sale Mersana Therapeutics, Inc.RoutineJan 14, 2025 +99 days
Sold 3,330 shares at $0.66 ($2k)
Carvajal Alejandra, SVP, Chief Legal Officer
10b5-1 planSold 4.6% of holdings ($48k position)69,344 shares left0.8x usual sizeFiling
- 6 Form 4 sale Mersana Therapeutics, Inc.RoutineJan 15, 2025 +1 day
Sold 952 shares at $0.63 ($600)
Carvajal Alejandra, SVP, Chief Legal Officer
10b5-1 planSold 1.3% of holdings ($45k position)70,892 shares left0.2x usual sizeFiling
- 7 Form 4 sale Mersana Therapeutics, Inc.RoutineJan 16, 2025 +1 day
Sold 5,096 shares at $0.58 ($3k)
Carvajal Alejandra, SVP, Chief Legal Officer
10b5-1 planSold 6.1% of holdings ($48k position)78,296 shares left1.4x usual sizeFiling
- 8 Form 144 notice Mersana Therapeutics, Inc.NoticeJan 17, 2025 +1 day
Filed to sell 5,096 shares ($3k)
Carvajal Alejandra, Officer
10b5-1 plan1.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (24)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 17, 2025 | Jan 17, 2025 | Mersana Therapeutics, Inc. | Officer | Form 144 notice | 5,096 | $3k | Notice | SEC | |
| Jan 16, 2025 | Jan 17, 2025 | Mersana Therapeutics, Inc. | SVP, Chief Legal Officer | Form 4 sale | 5,096 | $3k | 6.1% | Routine | SEC |
| Jan 15, 2025 | Jan 16, 2025 | Mersana Therapeutics, Inc. | SVP, Chief Legal Officer | Form 4 sale | 952 | $600 | 1.3% | Routine | SEC |
| Jan 14, 2025 | Jan 15, 2025 | Mersana Therapeutics, Inc. | SVP, Chief Legal Officer | Form 4 sale | 3,330 | $2k | 4.6% | Routine | SEC |
| Oct 7, 2024 | Oct 7, 2024 | Mersana Therapeutics, Inc. | Officer | Form 144 notice | 13,687 | $28k | Notice | SEC | |
| Oct 3, 2024 | Oct 7, 2024 | Mersana Therapeutics, Inc. | SVP, Chief Legal Officer | Form 4 sale | 13,687 | $27k | 17.7% | Unusual | SEC |
| Jan 16, 2024 | Jan 17, 2024 | Mersana Therapeutics, Inc. | SVP, Chief Legal Officer | Form 4 sale | 4,381 | $12k | 13.8% | Routine | SEC |
| Apr 27, 2023 | Apr 28, 2023 | Mersana Therapeutics, Inc. | SVP, Chief Legal Officer | Form 4 sale | 3,944 | $15k | 16.3% | Routine | SEC |
| Jan 17, 2023 | Jan 18, 2023 | Mersana Therapeutics, Inc. | SVP, Chief Legal Officer | Form 4 sale | 782 | $4k | 6.6% | Plan not stated | SEC |
| Apr 26, 2022 | Apr 28, 2022 | Mersana Therapeutics, Inc. | Chief Legal Officer | Form 4 sale | 3,948 | $15k | 29.8% | Unusual | SEC |
| Jul 20, 2020 | Jul 21, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Legal Officer | Form 4 sale | 1,087 | $37k | 3.6% | Plan not stated | SEC |
| Jun 30, 2020 | Jul 1, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Legal Officer | Form 4 sale | 6,811 | $239k | 19.9% | Plan not stated | SEC |
| Jun 12, 2020 | Jun 15, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Legal Officer | Form 4 sale | 6,756 | $204k | 26.0% | Unusual | SEC |
| Apr 20, 2020 | Apr 21, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Legal Officer | Form 4 sale | 1,124 | $33k | 9.3% | Plan not stated | SEC |
| Mar 6, 2020 | Mar 9, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Legal Officer | Form 4 sale | 5,302 | $154k | 35.3% | Unusual | SEC |
| Feb 14, 2020 | Feb 19, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Legal Officer | Form 4 sale | 6,892 | $217k | 100.0% | Unusual | SEC |
| Feb 13, 2020 | Feb 14, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Legal Officer | Form 4 sale | 3,108 | $93k | 31.1% | Unusual | SEC |
| Jan 22, 2020 | Jan 24, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Legal Officer | Form 4 sale | 1,577 | $46k | 100.0% | Unusual | SEC |
| Jan 21, 2020 | Jan 22, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Legal Officer | Form 4 sale | 860 | $26k | 35.3% | Unusual | SEC |
| Oct 21, 2019 | Oct 23, 2019 | MOMENTA PHARMACEUTICALS INC | Chief Legal Officer | Form 4 sale | 6,814 | $98k | 100.0% | Unusual | SEC |
| Oct 18, 2019 | Oct 21, 2019 | MOMENTA PHARMACEUTICALS INC | Chief Legal Officer | Form 4 sale | 2,936 | $41k | 30.1% | Unusual | SEC |
| Apr 29, 2019 | May 1, 2019 | MOMENTA PHARMACEUTICALS INC | Chief Legal Officer | Form 4 sale | 10,384 | $153k | 100.0% | Unusual | SEC |
| Feb 14, 2019 | Feb 19, 2019 | MOMENTA PHARMACEUTICALS INC | Chief Legal Officer | Form 4 sale | 703 | $9k | 4.4% | Plan not stated | SEC |
| Feb 13, 2019 | Feb 14, 2019 | MOMENTA PHARMACEUTICALS INC | Chief Legal Officer | Form 4 sale | 2,938 | $37k | 15.7% | Plan not stated | SEC |